Imagine a giant shared library, but instead of books, it holds the world's most powerful microscopes and imaging tools. This project is like upgrading that library's catalog and membership rules so any scientist or company can easily find and use the right tool. It makes sure the data coming out of these machines is organized and easy to share, like a universal digital filing system.
Companies often struggle to access expensive, high-end imaging equipment and standardized data across different borders. This creates a bottleneck in biomedical R&D and increases capital expenditure.
A next-generation Access Portal for imaging services and a set of standardized legal templates for strategic partnerships.
If you are a drug discovery firm dealing with high costs of purchasing specialized imaging hardware — this project developed a next-generation Access Portal that provides quality-assured access to over 120 cutting-edge imaging technologies. This allows you to outsource high-end imaging without investing in the equipment yourself.
If you are a biotech startup dealing with fragmented data formats from different labs — this project developed FAIR data services that standardize image results. This ensures your research data is compatible across 18 Member States, speeding up your path to validation.
If you are an imaging hardware manufacturer dealing with a lack of real-world user feedback — this project developed strengthened industry relations and a network of 173 individual imaging facilities. This provides a direct channel to see how your tools perform in a diverse, pan-European research environment.
Based on available project data, specific pricing is not listed, but the project focuses on streamlining legal and contractual practices to facilitate access to the infrastructure.
Yes, the infrastructure already consists of 35 National Nodes representing 173 individual imaging facilities across 16 European countries and EMBL.
The project is developing new legal templates and reviewing core organization policies to streamline strategic partnering and access.
The project period runs from 2024-03-01 to 2027-08-31.
The project provides FAIR data services to ensure that imaging data is findable, accessible, interoperable, and reusable.
The consortium is highly centralized, consisting of 3 research partners from Germany, Finland, and Italy. There are currently 0 industry partners or SMEs involved, meaning the project is driven entirely by research infrastructure organizations to build the foundation for future commercial use.
Contact EURO-BIOIMAGING ERIC in Finland for access to the imaging portal.
Contact SciTransfer to find the specific imaging node that fits your drug discovery pipeline.
